Breast Cancer: Professionals To Brainstorm On The Use Of The NCCN Harmonised Guidelines
All plans are underway for Health experts across the country to identify and explore the barriers and facilitators in the use of the Harmonised National Comprehensive Cancer Network (NCCN) guidelines in Nigeria at the upcoming one-day symposium on breast cancer organised by the Association of Radiation and Clinical Oncologist of Nigeria (ARCON). BLUEPRINTS reports.
The one-day symposium themed: “Optimizing the Standard of Care for Breast Cancer in Nigeria” will hold on the 30th of June, 2022 in Enugu State. Information Guide Nigeria
👉 Relocate to Canada Today!
Live, Study and Work in Canada. No Payment is Required! Hurry Now click here to Apply >> Immigrate to CanadaSee Other Top News:
- JUST IN: Tanko Muhammad To Resign As CJN
- SERAP Drags Buhari, Malami Over ‘Missing N11tr Electricity Fund’
- APC Solicits Kwankwaso, Rejects Atiku’s Chances Of Upstaging Tinubu
- INEC Explains Why List Excluded Lawan, Akpabio, Umahi as APC Senatorial Candidates
In a press release presented by Dr Nwamaka Lasebikan, the President of ARCON yesterday explained that the meeting will be hybrid to allow for maximum participation of key stakeholders offering care in the Oncology space. jamb results
She further explained that established in 2016, ARCON is a community of more than 100 professionals (specialist and trainees) with the aim of promoting ethical and evidence-based standard of care for cancer in our environment and aims to develop robust and competent cancer health solutions together with the government of Nigeria.
” Some of our objectives are to liaise with international bodies with similar goals, sensitize the Nigerian population about cancer and ways to combat the scourge and stigma, as well as encourage and advance the knowledge and practice of the science of Radiation and Clinical Oncology through Research, Education & Training, and knowledge dissemination via CMEs, Conferences, Workshops amongst others.
“Breast cancer is the most common cancer in women worldwide, however, the mortality rate and probability of surviving for up to or more than 5years in lower and middle-income countries like Nigeria falls short of what obtains in high-income countries.
“With the rapid advancement of new technologies and medications, this disparity continues to increase with clinical and patient outcomes related to the side of the globe you live in.
“This one-day symposium will feature lectures and panelist sessions from seasoned experts in oncology in a bid to close the care gap, improve clinical outcomes and quality of life of patients with breast cancer,” she said.
